CN103788020A - 沃替西汀的制备方法 - Google Patents
沃替西汀的制备方法 Download PDFInfo
- Publication number
- CN103788020A CN103788020A CN201410028213.5A CN201410028213A CN103788020A CN 103788020 A CN103788020 A CN 103788020A CN 201410028213 A CN201410028213 A CN 201410028213A CN 103788020 A CN103788020 A CN 103788020A
- Authority
- CN
- China
- Prior art keywords
- ting
- preparation
- compound
- replacement
- aniline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410028213.5A CN103788020B (zh) | 2014-01-22 | 2014-01-22 | 沃替西汀的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410028213.5A CN103788020B (zh) | 2014-01-22 | 2014-01-22 | 沃替西汀的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103788020A true CN103788020A (zh) | 2014-05-14 |
CN103788020B CN103788020B (zh) | 2015-11-04 |
Family
ID=50664128
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410028213.5A Active CN103788020B (zh) | 2014-01-22 | 2014-01-22 | 沃替西汀的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103788020B (zh) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104130212A (zh) * | 2014-07-01 | 2014-11-05 | 安徽省逸欣铭医药科技有限公司 | 一种适合氢溴酸沃替西汀工业化生产的合成方法 |
CN104230852A (zh) * | 2014-08-29 | 2014-12-24 | 成都倍特药业有限公司 | 沃替西汀的合成方法 |
CN104356092A (zh) * | 2014-11-27 | 2015-02-18 | 合肥创新医药技术有限公司 | 沃替西汀的制备方法 |
CN104447622A (zh) * | 2014-11-28 | 2015-03-25 | 郑州大明药物科技有限公司 | 氢溴酸沃替西汀β晶型的制备新方法 |
CN104725335A (zh) * | 2014-11-28 | 2015-06-24 | 郑州大明药物科技有限公司 | 高纯度氢溴酸沃替西汀的制备方法 |
WO2015114395A1 (en) | 2014-01-31 | 2015-08-06 | Egis Gyógyszergyár Zrt. | Process for the preparation of vortioxetine salts |
CN105037166A (zh) * | 2015-07-06 | 2015-11-11 | 广西科技大学 | 2,2-二(4-(4-氨基苯氧基)苯基)六氟丙烷及其中间体的制备方法 |
CN105152937A (zh) * | 2015-07-06 | 2015-12-16 | 广西科技大学 | 一种低温快速制备2,2-二(4-(4-氨基苯氧基)苯基)六氟丙烷及其中间体的方法 |
CN105541759A (zh) * | 2016-01-07 | 2016-05-04 | 美吉斯制药(厦门)有限公司 | 一种制备沃替西汀的新方法 |
CN105669594A (zh) * | 2014-11-19 | 2016-06-15 | 康普药业股份有限公司 | 抗抑郁症药1-[2-(2,4-二甲基苯基硫基)苯基]哌嗪的制备方法 |
WO2016079751A3 (en) * | 2014-11-17 | 2016-07-14 | Megafine Pharma (P) Ltd. | A process for preparation of vortioxetine and polymorphs thereof |
WO2016151328A1 (en) | 2015-03-26 | 2016-09-29 | Cipla Limited | Method for making serotonin reuptake inhibitors |
EP3166926A1 (en) * | 2014-07-08 | 2017-05-17 | Zentiva K.S. | Method of preparing vortioxetine |
US10428033B2 (en) | 2017-02-15 | 2019-10-01 | Piramal Enterprises Limited | Process for the preparation of vortioxetine and salts thereof |
CN115181077A (zh) * | 2022-07-27 | 2022-10-14 | 安徽峆一药业股份有限公司 | 一种低杂质含量的沃替西汀合成方法 |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005075410A1 (en) * | 2004-02-06 | 2005-08-18 | Active Biotech Ab | New compounds, methods for their preparation and use thereof |
CN101472906A (zh) * | 2006-06-16 | 2009-07-01 | H.隆德贝克有限公司 | 作为用于治疗认知损伤的、具有结合的对血清素再吸收、5-ht3和5-ht1a活性的化合物的1-[2-(2,4-二甲基苯基硫烷基)-苯基]哌嗪 |
CN101505762A (zh) * | 2005-12-22 | 2009-08-12 | 康福玛医药公司 | 热休克蛋白90的口服活性嘌呤基抑制剂 |
CN102317272A (zh) * | 2009-02-17 | 2012-01-11 | H.隆德贝克有限公司 | 1-[2-(2,4-二甲基苯基硫基)苯基]哌嗪的提纯 |
EP2220076B1 (en) * | 2007-11-15 | 2012-01-18 | Boehringer Ingelheim International GmbH | Inhibitors of human immunodeficiency virus replication |
CN102464654A (zh) * | 2010-11-12 | 2012-05-23 | 上海泓博智源医药技术有限公司 | 新型抗病毒化合物 |
WO2013026455A1 (en) * | 2011-08-24 | 2013-02-28 | Aarhus Universitet | Permanently positively charged antidepressants |
WO2013102573A1 (en) * | 2012-01-03 | 2013-07-11 | H. Lundbeck A/S | Process for the manufacture of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]-piperazine |
CN103275032A (zh) * | 2013-06-06 | 2013-09-04 | 中科院广州化学有限公司 | 一种4-芳基-6-甲氧羰基苯并噁嗪类化合物的制备方法 |
CN103351338A (zh) * | 2013-06-17 | 2013-10-16 | 张家港威胜生物医药有限公司 | 一种盐酸去甲乌药碱的简易制备工艺 |
CN103408551A (zh) * | 2013-07-25 | 2013-11-27 | 苏州明锐医药科技有限公司 | 阿立塞替的制备方法 |
-
2014
- 2014-01-22 CN CN201410028213.5A patent/CN103788020B/zh active Active
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005075410A1 (en) * | 2004-02-06 | 2005-08-18 | Active Biotech Ab | New compounds, methods for their preparation and use thereof |
CN101505762A (zh) * | 2005-12-22 | 2009-08-12 | 康福玛医药公司 | 热休克蛋白90的口服活性嘌呤基抑制剂 |
CN101472906A (zh) * | 2006-06-16 | 2009-07-01 | H.隆德贝克有限公司 | 作为用于治疗认知损伤的、具有结合的对血清素再吸收、5-ht3和5-ht1a活性的化合物的1-[2-(2,4-二甲基苯基硫烷基)-苯基]哌嗪 |
EP2220076B1 (en) * | 2007-11-15 | 2012-01-18 | Boehringer Ingelheim International GmbH | Inhibitors of human immunodeficiency virus replication |
CN102317272A (zh) * | 2009-02-17 | 2012-01-11 | H.隆德贝克有限公司 | 1-[2-(2,4-二甲基苯基硫基)苯基]哌嗪的提纯 |
CN102464654A (zh) * | 2010-11-12 | 2012-05-23 | 上海泓博智源医药技术有限公司 | 新型抗病毒化合物 |
WO2013026455A1 (en) * | 2011-08-24 | 2013-02-28 | Aarhus Universitet | Permanently positively charged antidepressants |
WO2013102573A1 (en) * | 2012-01-03 | 2013-07-11 | H. Lundbeck A/S | Process for the manufacture of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]-piperazine |
CN103275032A (zh) * | 2013-06-06 | 2013-09-04 | 中科院广州化学有限公司 | 一种4-芳基-6-甲氧羰基苯并噁嗪类化合物的制备方法 |
CN103351338A (zh) * | 2013-06-17 | 2013-10-16 | 张家港威胜生物医药有限公司 | 一种盐酸去甲乌药碱的简易制备工艺 |
CN103408551A (zh) * | 2013-07-25 | 2013-11-27 | 苏州明锐医药科技有限公司 | 阿立塞替的制备方法 |
Non-Patent Citations (2)
Title |
---|
BENNY BANG-ANDERSEN ET AL.: "Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder", 《JOURNAL OF MEDICINAL CHEMISTRY》 * |
史少辉 等: "硫醚合成研究进展", 《广州化工》 * |
Cited By (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA029060B1 (ru) * | 2014-01-31 | 2018-02-28 | Эгиш Дьёдьсердьяр Зрт. | Способ получения солей вортиоксетина |
US9822086B2 (en) | 2014-01-31 | 2017-11-21 | Egis Gyogyszergyar Zrt. | Process for the preparation of vortioxetine salts |
WO2015114395A1 (en) | 2014-01-31 | 2015-08-06 | Egis Gyógyszergyár Zrt. | Process for the preparation of vortioxetine salts |
CN106103418A (zh) * | 2014-01-31 | 2016-11-09 | 埃吉斯药物私人有限公司 | 沃替西汀盐的制备方法 |
CN104130212A (zh) * | 2014-07-01 | 2014-11-05 | 安徽省逸欣铭医药科技有限公司 | 一种适合氢溴酸沃替西汀工业化生产的合成方法 |
CN104130212B (zh) * | 2014-07-01 | 2016-08-24 | 安徽省逸欣铭医药科技有限公司 | 一种适合氢溴酸沃替西汀工业化生产的合成方法 |
EP3166926A1 (en) * | 2014-07-08 | 2017-05-17 | Zentiva K.S. | Method of preparing vortioxetine |
CN104230852A (zh) * | 2014-08-29 | 2014-12-24 | 成都倍特药业有限公司 | 沃替西汀的合成方法 |
CN104230852B (zh) * | 2014-08-29 | 2017-03-29 | 桑迪亚医药技术(上海)有限责任公司 | 沃替西汀的合成方法 |
WO2016079751A3 (en) * | 2014-11-17 | 2016-07-14 | Megafine Pharma (P) Ltd. | A process for preparation of vortioxetine and polymorphs thereof |
CN105669594A (zh) * | 2014-11-19 | 2016-06-15 | 康普药业股份有限公司 | 抗抑郁症药1-[2-(2,4-二甲基苯基硫基)苯基]哌嗪的制备方法 |
CN104356092A (zh) * | 2014-11-27 | 2015-02-18 | 合肥创新医药技术有限公司 | 沃替西汀的制备方法 |
CN104356092B (zh) * | 2014-11-27 | 2017-03-22 | 合肥创新医药技术有限公司 | 沃替西汀的制备方法 |
CN104725335A (zh) * | 2014-11-28 | 2015-06-24 | 郑州大明药物科技有限公司 | 高纯度氢溴酸沃替西汀的制备方法 |
CN104725335B (zh) * | 2014-11-28 | 2017-03-08 | 郑州大明药物科技有限公司 | 高纯度氢溴酸沃替西汀的制备方法 |
CN104447622A (zh) * | 2014-11-28 | 2015-03-25 | 郑州大明药物科技有限公司 | 氢溴酸沃替西汀β晶型的制备新方法 |
WO2016151328A1 (en) | 2015-03-26 | 2016-09-29 | Cipla Limited | Method for making serotonin reuptake inhibitors |
CN105152937A (zh) * | 2015-07-06 | 2015-12-16 | 广西科技大学 | 一种低温快速制备2,2-二(4-(4-氨基苯氧基)苯基)六氟丙烷及其中间体的方法 |
CN105037166A (zh) * | 2015-07-06 | 2015-11-11 | 广西科技大学 | 2,2-二(4-(4-氨基苯氧基)苯基)六氟丙烷及其中间体的制备方法 |
CN105541759A (zh) * | 2016-01-07 | 2016-05-04 | 美吉斯制药(厦门)有限公司 | 一种制备沃替西汀的新方法 |
US10428033B2 (en) | 2017-02-15 | 2019-10-01 | Piramal Enterprises Limited | Process for the preparation of vortioxetine and salts thereof |
CN115181077A (zh) * | 2022-07-27 | 2022-10-14 | 安徽峆一药业股份有限公司 | 一种低杂质含量的沃替西汀合成方法 |
CN115181077B (zh) * | 2022-07-27 | 2024-03-29 | 安徽峆一药业股份有限公司 | 一种低杂质含量的沃替西汀合成方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103788020B (zh) | 2015-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103788020B (zh) | 沃替西汀的制备方法 | |
CN103788019B (zh) | 沃替西汀的制备方法 | |
CN103992262B (zh) | 塞瑞替尼及其中间体的制备方法 | |
EP2736894B1 (en) | Method for producing benzo[b] thiophene compounds | |
CN105820110B (zh) | 匹莫范色林合成方法 | |
CN104098530B (zh) | 一种沃替西汀的制备方法 | |
CN104230852B (zh) | 沃替西汀的合成方法 | |
CN103936694A (zh) | 一种抗抑郁药沃替西汀的制备方法 | |
NO340420B1 (no) | Metode for fremstilling av 1-(3-(2-(1-benzotiofen-5-yl)-etoksy)propyl)azetidin-3-ol eller salter derav | |
CN105283442A (zh) | 用于合成1-(2-((2,4-二甲基苯基)硫代)苯基)哌嗪的新方法 | |
CN103108869A (zh) | 制备氨基苯甲酰基苯并呋喃衍生物的方法 | |
CN104447515B (zh) | 制备色瑞替尼的新中间体及其制备方法 | |
KR20150118146A (ko) | 보르티옥세틴 제조 방법 | |
CN105399736A (zh) | 一种依匹哌唑新的制备方法 | |
CN105198821B (zh) | 洛昔替尼的制备方法 | |
CN104262232A (zh) | 尼泰达尼的制备方法 | |
CN104356092A (zh) | 沃替西汀的制备方法 | |
JP2022508494A (ja) | モルホリノキナゾリン化合物の製造方法及びその中間体 | |
CN106458943A (zh) | 通过(2,4‑二甲基苯基)(2‑碘苯基)硫烷中间体合成沃替西汀 | |
CN103694176B (zh) | 尼洛替尼中间体的制备方法 | |
CN1993314B (zh) | 非对映异构选择性还原胺化方法 | |
CN105348220B (zh) | 一种氢溴酸沃替西汀的合成方法 | |
CN109422722A (zh) | 一种苯并噻吩化合物中间体的制备方法 | |
CN104292183A (zh) | 一种抗抑郁药物沃替西汀的制备方法 | |
CN107522742B (zh) | 一种Brigatinib关键中间体的均相“一锅法”制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201012 Address after: 215600 station 0002, 20th floor, building A-1, shazhouhu science and Technology Innovation Park, Huachang Road, yangshe Town, Zhangjiagang City, Suzhou City, Jiangsu Province (cluster registration) Patentee after: Youbiao e-commerce (Suzhou) Co., Ltd Address before: 215000 Jiangsu Province, Suzhou City Industrial Park Commercial Plaza Building 1 room 1305 Lianfeng Patentee before: SUZHOU MIRACPHARMA TECHNOLOGY Co.,Ltd. Patentee before: Xu Xuenong |